focus -WSS

focus

author：focus 2025-08-23 08:56:32 - browse：8

light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece — Pfizer CEO Albert Bourla was one of a few pharmaceutical executives who donated to a failed Senate campaign in New Jersey. Giannis Papanikos/AP

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Administration infighting over the national stockpile

The health department’s preparedness office overseeing national stockpiles of emergency medical gear is trying to cement its Covid-era power — and meeting with congressional skepticism.

The Administration for Strategic Preparedness and Response has seen demands for protective gear and therapies rapidly expand between the Covid-19 pandemic, the 2022 mpox outbreak, and now the spread of avian flu among cows. But its management of the nation’s medical stockpile — and its efforts to replenish depleting stock — are under fresh scrutiny from lawmakers. In particular, Republicans want answers on the $850 million that Congress clawed back from ASPR’s budget, and on why that cash wasn’t spent if the stockpile needed it so badly, my co-author Sarah Owermohle reports.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Surgery pushed Ben Carson to fame

WSS

AI models in health care face new federal disclosure requirements

AI models in health care face new federal disclosure requirements

The woman behind the Dana Farber

Why Novartis is going to walk from its acquisition of MorphoSys

Radiology is caught between AI's potential and concern for patients

What PEPFAR has meant on the ground in Ukraine

Wikipedia

focus

Administration infighting over the national stockpile

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

Virginia high school admissions case could be legal follow

Chemotherapy shortages won’t get better under Biden’s latest plan

How one medical school became remarkably diverse

Chemotherapy shortages won’t get better under Biden’s latest plan

Drug repurposing or repositioning? The language matters

Roche to buy Carmot Therapeutics, developer of obesity drugs

Psychedelics group wrestles with new pharma identity

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Medicare details structure of new drug price negotiation program

Readout LOUD: Venture capital, Gilead, and more M&A

knowledge

The CDC's new social media misinformation war

Surgery pushed Ben Carson to fame

Adopting new red light myopia treatments may be short

What causes an itch? Researchers may have solved the mystery

AI gets buy

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

leisure time

hotspot

explore

hotspot